Gauri A J, Raxwal V K, Roux L, Fearon W F, Froelicher V F
Division of Cardiovascular Medicine, Stanford University Medical Center, Palo Alto, CA, USA.
Am Heart J. 2001 Jul;142(1):136-41. doi: 10.1067/mhj.2001.115788.
Our purpose was to assess the diagnostic characteristics of the exercise test in patients who fail to reach conventional target heart rates and in patients on beta-blockers.
Exercise test results are often considered "inadequate" or "nondiagnostic" in patients taking beta-blockers and in patients who do not achieve 85% of their age-predicted maximal heart rate.
The results of exercise tests and coronary angiography performed to evaluate chest pain in 1282 male patients without a prior history of myocardial infarction, coronary revascularization, diagnostic Q wave on the baseline electrocardiogram, or previous cardiac catheterization were analyzed with respect to beta-blocker exposure and failure to reach 85% age-predicted maximal heart rate. Sensitivity, specificity, and predictive accuracy of exercise testing, as well as area under the curve for the receiver operating characteristic plots were calculated for these subgroups with use of coronary angiography as the reference. The angiographic criterion for significant coronary artery disease was 50% narrowing or greater in one or more major coronary arteries.
The population was divided into 4 exclusive groups on the basis of whether they reached their target heart rates and whether they were receiving beta-blockers. Sixty to 40 percent of this clinical population failed to reach target heart rate, of which 24% (n = 303) were receiving beta-blockers and 40% (n = 518) were not. The group of patients who reached target heart rate and were not taking beta-blockers was taken as the reference group (n = 409). The group of patients supposedly beta-blocked but who reached the target heart rate (n = 52) had hemodynamic and test characteristics similar to those of the reference group and most likely were not taking their beta-blockers or were not adequately dosed. The prevalence of angiographic coronary disease was significantly higher in the 2 groups failing to reach target heart rate, both in the presence and absence of beta-blockers, compared with the reference group (68% and 64%, respectively, vs 49%, P <.01). Although the areas under the curve of the receiver operating characteristic curves for ST depression of the groups failing to reach target heart rate were not significantly different from the reference group, the predictive accuracy and sensitivity were significantly lower for 1 mm of ST depression in the beta-blocked group who did not reach target heart rate (predictive accuracy of 56% vs 67%, sensitivity of 44% vs 58%, P <.01). The only way to maintain sensitivity with the standard exercise test in the beta-blocker group who failed to reach target heart rate was to use a treadmill score or 0.5-mm ST depression as the criteria for abnormal.
Sensitivity and predictive accuracy of standard ST criteria for exercise-induced ST depression are significantly decreased in male patients who are taking beta-blockers and do not reach target heart rate. In those who fail to reach target heart rate and are not beta-blocked, sensitivity and predictive accuracy are maintained.
我们的目的是评估运动试验在未达到传统目标心率的患者以及服用β受体阻滞剂的患者中的诊断特征。
在服用β受体阻滞剂的患者以及未达到其年龄预测最大心率85%的患者中,运动试验结果常被认为“不充分”或“无诊断价值”。
对1282例无心肌梗死病史、冠状动脉血运重建史、基线心电图无诊断性Q波或既往未行心导管检查的男性患者进行运动试验和冠状动脉造影以评估胸痛情况,分析其β受体阻滞剂使用情况以及未达到年龄预测最大心率85%的情况。以冠状动脉造影为参考,计算这些亚组运动试验的敏感性、特异性和预测准确性,以及受试者工作特征曲线下面积。冠状动脉疾病的血管造影标准为一条或多条主要冠状动脉狭窄50%或更严重。
根据是否达到目标心率以及是否服用β受体阻滞剂,将研究人群分为4个相互独立的组。该临床人群中有60%至40%未达到目标心率,其中24%(n = 303)服用β受体阻滞剂,40%(n = 518)未服用。达到目标心率且未服用β受体阻滞剂的患者组作为参考组(n = 409)。推测服用β受体阻滞剂但达到目标心率的患者组(n = 52)的血流动力学和试验特征与参考组相似,很可能未服用β受体阻滞剂或剂量不足。与参考组相比,未达到目标心率的两组患者(无论是否服用β受体阻滞剂)血管造影显示冠状动脉疾病的患病率均显著更高(分别为68%和64%,对比49%,P <.01)。虽然未达到目标心率的组ST段压低的受试者工作特征曲线下面积与参考组无显著差异,但未达到目标心率的服用β受体阻滞剂组中ST段压低1mm时的预测准确性和敏感性显著更低(预测准确性分别为56%对比67%,敏感性分别为44%对比58%,P <.01)。在未达到目标心率的服用β受体阻滞剂组中,使用标准运动试验维持敏感性的唯一方法是将跑步机评分或0.5mm ST段压低作为异常标准。
在服用β受体阻滞剂且未达到目标心率的男性患者中,运动诱发ST段压低的标准ST标准的敏感性和预测准确性显著降低。在未达到目标心率且未服用β受体阻滞剂的患者中,敏感性和预测准确性得以维持。